GDUFA Research Outcomes
OA Models
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to computational modeling of absorption for orally administered drugs to support generic product development and assessment.
-
Physiologically Based Pharmacokinetic Modeling for BCS IV Drugs and Case Examples
Wu, Fang
-
Physiologically Based Pharmacokinetic Absorption Modeling to Support BCS-Based Waiver of In Vivo Bioequivalence Studies
Wu, Fang
-
Totality of Evidence Including PBPK Modeling to Support BE Assessment and Approval of Mesalamine Delayed Release Tablets (Part II)
Wu, Fang
-
Regulatory Perspective of Model Master Files Utilities for Oral Drug Products
Wu, Fang
-
Using Physiologically Based Pharmacokinetic Absorption Modeling for Bioequivalence Evaluation in Adult and Pediatric Populations
Wu, Fang
-
Advances on Using PBPK Modeling to Support BE Assessment for Oral Products
Wu, Fang
-
PBPK Modeling for Setting PSD Specifications
Wu, Fang
-
OGD Perspectives on PBBM Applications for Generics
Wu, Fang
-
Using Physiologically Based Pharmacokinetic Absorption Modeling for Bioequivalence Evaluation in Adult and Pediatric Populations
Wu, Fang
-
A Critical Overview of the Biological Effects of Excipients
Wu, Fang; Tsakalozou, Eleftheria